Dysfunction of KCC2 is associated with several neurological and psychiatric disorders, including epilepsy, neuropathic pain, spasticity, ischemic insults, brain trauma, schizophrenia, and autism (44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54). This evidence concerns the gene SLC12A5 and epilepsy.